Evercore ISI Group Maintains In-Line on Hologic, Lowers Price Target to $76
Portfolio Pulse from Benzinga Newsdesk
Evercore ISI Group analyst Vijay Kumar maintains an In-Line rating on Hologic (NASDAQ:HOLX) but lowers the price target from $78 to $76.
July 02, 2024 | 3:42 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Evercore ISI Group analyst Vijay Kumar maintains an In-Line rating on Hologic but lowers the price target from $78 to $76.
The lowered price target from $78 to $76 suggests a slightly less optimistic outlook for Hologic, which could lead to a short-term negative impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100